PIM1 and hematopoietic and lymphoid cell neoplasm: To confirm that the observed antiproliferative effects of INCB053914 in hematologic tumor cell lines were due to PIM inhibition, the effects of INCB053914 on PIM kinase-mediated signaling networks were investigated.